Key facts
- EirSystems’s last known valuation is $4.3M (Sep 2022).
- It has raised $1.8M across 2 recorded rounds; the latest was Seed Round ($250K) in Feb 2022.
- Notable investors include Launch Tennessee, InvestTN, Chain Reaction Boston, Solas BioVentures.
- EirSystems has filed 4 Form Ds with the SEC since 2019, most recently Apr 2022 ($250K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for EirSystems
Funding rounds
2 roundsAbout EirSystems
Developer of e-prescribing and medical reconciliation technology designed to reduce inefficiencies and increase interoperability in healthcare services. The company's platform uses distributed ledger technology that acts as a supply chain manager for the prescribing process, enabling clients to track and oversee prescription medicines easily.
- Sector
- Healthcare
- HQ
- Chattanooga, TN, United States
- Founded
- 2018
- Employees
- 10
- Website
- eirsystems.net/
- Ownership
- Privately Held (backing)
EirSystems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EirSystems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EirSystems in its N-PORT filings yet. We sweep new filings monthly.